Wolverine Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Wolverine Trading’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,200	Closed	-$17K	–	6251
2022 Q1	$17K	Buy	21,200 +7,000	+49%	+$6.42K	﹤0.01%	5267
2021 Q4	$15K	Sell	14,200 -600	-4%	-$845	﹤0.01%	5528
2021 Q3	$25K	Buy	+14,800	New	+$24.9K	﹤0.01%	6123
2021 Q1	–	Sell	-17,300	Closed	-$35K	–	6654
2020 Q4	$35K	Buy	+17,300	New	+$40.8K	﹤0.01%	4657
2020 Q1	–	Sell	-12,300	Closed	-$15K	–	5708
2019 Q4	$15K	Buy	+12,300	New	+$10.6K	﹤0.01%	4558
2017 Q2	–	Sell	-915	Closed	-$10K	–	5309
2017 Q1	$10K	Buy	915 +255	+39%	+$2.9K	﹤0.01%	4121
2016 Q4	$8K	Buy	+660	New	+$10.5K	﹤0.01%	4346

Other funds holding NAVB

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wolverine Trading's NAVB Position: Q2 2023 in Review

Wolverine Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 16,297 shares — an estimated $5K sold.

Wolverine Trading first reported a position in NAVB in Q2 2017 and held it in 9 quarters. The position peaked at $60K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

Wolverine Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
Wolverine Trading sold 16,297 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $5K.
Wolverine Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2017 and held it in 9 quarters.
Wolverine Trading's Navidea Biopharmaceuticals Inc. position peaked at $60K in Q2 2020.
23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.